Intrinsic Value of S&P & Nasdaq Contact Us

Reneo Pharmaceuticals, Inc. RPHM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Reneo Pharmaceuticals, Inc. (RPHM) has 18 known insider and institutional holders on record. The largest holder is Leonard Braden Michael with 3,388,649 shares. Other notable holders include Novo Holdings A/S and FLESHER GREGORY J..

RPHM Insider Ownership

Top Holder
Leonard Braden Michael
3,388,649 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Leonard Braden Michael 10 Percent Owner 3,388,649 2024-09-26
100%
2 Novo Holdings A/s 10 Percent Owner 3,330,337 2023-06-23
98%
3 Flesher Gregory J. President and CEO 300,000 2022-12-13
9%
4 Cruse Michael Chief Operating Officer 125,000 2022-12-13
4%
5 Lam Jennifer VP of Finance & Administration 90,000 2022-12-13
3%
6 Hall Ashley Chief Development Officer 39,600 2023-08-29
1%
7 Jindal Vineet R. Chief Financial Officer 36,600 2021-12-14
1%
8 Dorenbaum Alejandro Chief Medical Officer 30,000 2022-12-13
1%
9 Dube Eric M Director 17,500 2023-06-08
1%
10 Hoelscher Paul W. Director 17,500 2023-06-08
1%
11 Seltzer Stacey Denenberg Director 17,500 2023-06-08
1%
12 Grey Michael G Executive Chairman 17,500 2023-06-08
1%
13 Muralidhar Bali Director 17,500 2023-06-08
1%
14 O'donnell Niall Director 17,500 2023-06-08
1%
15 Mathers Edward T Director 17,500 2023-06-08
1%
16 Blunt Roshawn A. Director 14,815 2023-06-08
0%
17 Cardon Lon Director 14,000 2021-04-12
0%
18 Harrison Kenneth Ph.d. Director 14,000 2021-04-12
0%

No ownership data available for RPHM.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message